Pandemic and Politics Shaped Pharma and FDA in 2022
PharmExec
DECEMBER 8, 2022
Year characterized by mix of key advances, contentious stances.
pandemic-and-politics-shaped-pharma-and-fda-in-2022 
59 
Pandemic and Politics Shaped Pharma and FDA in 2022
BioPharm
DECEMBER 1, 2022
Health crises, political tension, and budget concerns were major challenges.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Digital clinical trials: Trends to watch in 2023
Pharmaceutical Technology
APRIL 13, 2023
Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors.
FDA AdCom votes unanimously in favour of OTC oral contraceptive
Pharmaceutical Technology
MAY 11, 2023
A US Food and Drug Administration (FDA) Advisory Committee (AdCom) has voted unanimously in favour of giving HRA Pharma’s Opill (norgestrel) over-the-counter (OTC) availability. The FDA has no obligations to follow the recommendation of AdComs, though the vote will likely be weighed in the agency’s final decision.
Let's personalize your content